Subsequently, blockade of the PD‐1/PD‐L1 axis has demonstrated favorable antitumor effects and achieved an impressive breakthrough in cancer immune therapy for several types of cancer including melanoma, non‐small cell lung cancer (NSCLC), and gastrointestinal (GI) cancer.5, 6, 7, 8. Here, CD274 is linked to non-small cell lung carcinoma.